OMN6 a novel bioengineered peptide for the treatment of multidrug resistant Gram negative bacteria
Abstract New antimicrobial agents are urgently needed, especially to eliminate multidrug resistant Gram-negative bacteria that stand for most antibiotic-resistant threats. In the following study, we present superior properties of an engineered antimicrobial peptide, OMN6, a 40-amino acid cyclic pept...
Guardado en:
Autores principales: | Shira Mandel, Janna Michaeli, Noa Nur, Isabelle Erbetti, Jonathan Zazoun, Livia Ferrari, Antonio Felici, Moshe Cohen-Kutner, Niv Bachnoff |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/83a72ed367e14c80809b6afdced28df3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
New Multidrug Efflux Inhibitors for Gram-Negative Bacteria
por: Robert L. Marshall, et al.
Publicado: (2020) -
Bioengineering
Publicado: (2014) -
La máxima "Quod omnes tangit": Una aproximación al estado del tema
por: Merello Arecco,Italo
Publicado: (2005) -
Prevalence and characterisation of carbapenemase encoding genes in multidrug-resistant Gram-negative bacilli.
por: Sayran Hamad Haji, et al.
Publicado: (2021) -
Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens
por: Yves Briers, et al.
Publicado: (2014)